The Quantikine Human Amphiregulin Immunoassay is a 4.5 hour solid
phase ELISA designed to measure human Amphiregulin in cell culture
supernates, cell lysates serum, plasma, saliva, and urine. It contains E. coli-derived
recombinant human Amphiregulin and has been shown to accurately quantitate the recombinant factor.
Results obtained with natural human Amphiregulin showed
...linear curves that were parallel to the standard curves obtained using
the Quantikine kit standards. These results indicate that this kit can
be used to determine relative mass values for natural human Amphiregulin.
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human Amphiregulin Quantikine ELISA Kit
Colorectum cell-derived growth factor
schwannoma-derived growth factor
Amphiregulin (AR) is an EGF family growth factor that is released as a soluble protein following proteolytic cleavage of its transmembrane precursor. Amphiregulin is expressed by numerous carcinoma cell lines and epithelial cells of the colon, stomach, breast, ovary and kidney. It acts through ErbB family of receptor to stimulate the proliferation of keratinocytes, mammary epithelial cells, fibroblasts, astrocytes and glial cells. Amphiregulin can also inhibit the growth of certain tumor cells.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.